Top

Published in:

Open Access 01-12-2020 | SARS-CoV-2 | Research letter

Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey

Authors: Susan J. Tzotzos, Bernhard Fischer, Hendrik Fischer, Markus Zeitlinger

Published in: Critical Care | Issue 1/2020

Excerpt

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appeared just over 7 months ago in Wuhan, China. Early reports from China indicated that although some cases are asymptomatic, 20% of COVID-19 cases follow a severe course, necessitating hospitalization, with a quarter of hospitalized patients requiring intensive care unit (ICU) facilities [1]. Later reports from China and other countries substantiated these data, although ICU admission rates, proportion of patients receiving invasive mechanical ventilation (IMV), and mortality rates differ considerably between studies [2]. …

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020. https://doi.org/10.1001/jama.2020.2648.

Wunsch H. Mechanical ventilation in COVID-19: interpreting the current epidemiology. Am J Respir Crit Care Med. 2020;202(1):1–4. https://doi.org/10.1164/rccm.202004-1385ED.CrossRefPubMedPubMedCentral

Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020. https://doi.org/10.1001/jamainternmed.2020.0994.

Definition Task Force ARDS, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–33. https://doi.org/10.1001/jama.2012.5669.CrossRef

Fan E, Beitler JR, Brochard L, et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med. 2020:S2213–2600(20)30304–0. https://doi.org/10.1016/S2213-2600(20)30304-0.

Matthay MA, Aldrich JM, Gotts JE. Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med. 2020;8(5):433–4. https://doi.org/10.1016/S2213-2600(20)30127-2.CrossRefPubMedPubMedCentral

Title: Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey
Authors: Susan J. Tzotzos
Bernhard Fischer
Hendrik Fischer
Markus Zeitlinger
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: SARS-CoV-2
Acute Respiratory Distress-Syndrome
COVID-19
Published in: Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/s13054-020-03240-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series

Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis

Nutrition therapy in critical illness: a review of the literature for clinicians

Bedside calculation of mechanical power during volume- and pressure-controlled mechanical ventilation

COVID-19: more than a cytokine storm

COVID-19 and ethics in the ICU